Cataplexy-Free Days in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Narcolepsy With Cataplexy (2065)
Yves Dauvilliers(Inserm), Michael J. Thorpy(Albert Einstein College of Medicine), Karel Šonka(Charles University), Richard Bogan(University of South Carolina), Judi Profant(Jazz Pharmaceuticals (United States)), Lin Huang(Sun Yat-sen University), Nancy Foldvary‐Schaefer(Cleveland Clinic)
Cited by 1
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Narcolepsy with cataplexy
|The Lancet|2007|716
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
|Nature Reviews Neurology|2019|634
REM sleep behaviour disorder
|Nature Reviews Disease Primers|2018|498